MERZ NORTH AMERICA, INC.

MERZ NORTH AMERICA, INC. logo
🇺🇸United States
Ownership
Subsidiary
Established
1908-01-01
Employees
501
Market Cap
-
Website
http://www.merzusa.com

Evaluation of the MJGS Following Radiesse (+) Injection Into the Jawline

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2016-09-16
Last Posted Date
2020-12-10
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
29
Registration Number
NCT02904057

Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older

Phase 3
Withdrawn
Conditions
Interventions
First Posted Date
2016-02-09
Last Posted Date
2016-09-09
Lead Sponsor
Merz North America, Inc.
Registration Number
NCT02677610

Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older

Phase 3
Withdrawn
Conditions
Interventions
First Posted Date
2016-02-09
Last Posted Date
2016-09-09
Lead Sponsor
Merz North America, Inc.
Registration Number
NCT02677636

Safety and Efficacy of NAFT900 in Children With Tinea Capitis

First Posted Date
2016-01-18
Last Posted Date
2016-09-09
Lead Sponsor
Merz North America, Inc.
Registration Number
NCT02658292

Neurogenic Dysphonia/Dysphagia Registry

First Posted Date
2015-07-09
Last Posted Date
2016-09-09
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
146
Registration Number
NCT02493491
Locations
🇺🇸

Merz Clinical Site 0010334, New York, New York, United States

🇺🇸

Merz Clinical Site, Norfolk, Virginia, United States

🇺🇸

Merz Clinical Site 0010068, New York, New York, United States

and more 2 locations

An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis

First Posted Date
2015-06-09
Last Posted Date
2016-10-28
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
27
Registration Number
NCT02466867
Locations
🇭🇳

Merz Investigative Site #504001, San Pedro Sula, Honduras

🇺🇸

Merz Investigative Site#001261, College Station, Texas, United States

🇩🇴

Merz Investigative Site#180001, Santo Domingo, Dominican Republic

Pediatric Subjects With Tinea Corporis

Phase 4
Completed
Conditions
Interventions
First Posted Date
2014-08-28
Last Posted Date
2016-10-28
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
230
Registration Number
NCT02227290
Locations
🇵🇦

Merz Investigative Site#507001, Panama City, Panama

🇵🇷

Merz Investigative Site#001279, Cidra, Puerto Rico

🇺🇸

Merz Investigative Site#001097, Nashville, Tennessee, United States

and more 16 locations

The Treatment of Glabellar Frown Lines

First Posted Date
2014-03-26
Last Posted Date
2017-10-19
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
250
Registration Number
NCT02096081
Locations
🇺🇸

Merz Investigative Site #001300, Sacramento, California, United States

🇺🇸

Merz Investigative Site #001099, Los Angeles, California, United States

🇺🇸

Merz Investigative Site #001299, Santa Monica, California, United States

and more 7 locations

Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris

First Posted Date
2013-06-24
Last Posted Date
2015-04-15
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
65
Registration Number
NCT01885156
Locations
🇧🇿

Merz Investigational Site # 501001, Belize City, Belize

🇧🇿

Merz Investigational Site # 501002, Belize City, Belize

🇩🇴

Merz Investigative Site # 180001, Santo Domingo, Dominican Republic

and more 2 locations

Evaluation of Radiesse® Dermal Filler for Hand Treatment

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2013-04-15
Last Posted Date
2017-10-19
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
118
Registration Number
NCT01832090
Locations
🇺🇸

Merz Investigative Site #003, Nashville, Tennessee, United States

🇺🇸

Merz Investigative Site #001, Plano, Texas, United States

🇺🇸

Merz Investigative Site #007, Vista, California, United States

and more 3 locations
© Copyright 2024. All Rights Reserved by MedPath